Pituitary adenylate cyclase activating polypeptide (PACAP): Occurrence and vasodilatory effect in the human uteroplacental unit

Regulatory Peptides

Volumn 61, Issue 3, 1996, Pages 197-204

  Steenstrup, Birgit Ravn ^a   Jørgensen, Jørgen Christen ^a   Alm, Per ^b   Hannibal, Jens ^a   Junge, Jette ^a   Fahrenkrug, Jan ^a   Ottesen, Bent ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Immunochemistry; Immunocytochemistry; Intramyometrial artery; Pregnancy; Stem villous artery

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; NEUROPEPTIDE; NORADRENALIN; PROSTAGLANDIN F2 ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; PREGNANCY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOOTH MUSCLE CONTRACTION; UMBILICAL CORD; UTERUS RELAXATION; VASODILATATION;

EID: 0029967567     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(95)00156-5     Document Type: Article

References (32)

1. Miyata, A., Arimura, A., Dahl, R.R., Minamino, N., Uehara, A., Jiang, L, Culler, M.D. and Coy, D.H., Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells, Biochem. Biophys. Res. Commun., 164 (1989) 567-574.
2. Kimura, C., Ohkubo, S., Ogi, K., Hosya, M., Itoh, Y., Onda, H., Miyata, A., Jiang, L., Dahl, R.R., Stibbs, H.H., Arimura, A. and Fujino, M., A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs, Biochem. Biophys. Res. Commun., 166 (1990) 81-89.
3. Miyata, A., Jiang, L. and Dahl, R.D., Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP-38), Biochem. Biophys. Res. Commun., 170 (1990) 643-648.
4. Arimura, A., Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research, Regul. Pept., 37 (1992) 287-303.
5. Arimura, A., Somogyvári-Vigh, A., Miyata, A., Mizuno, K., Coy, D.H. and Kitada, C., Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes, Endocrinology, 129 (1991) 2787-2789.
6. Sundler, F., Ekblad, F., Absood, A., Håkanson, R., Köves, K. and Arimura, A., Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut, Neuroscience, 46 (1992) 439-454.
7. Uddman, R., Luts, A., Arimura, A. and Sundler, F., Pituitary adenylate cyclase activating peptide (PACAP), a new vasoactive intestinal (VIP)-like peptide in the respiratory tract, Cell Tissue Res., 265 (1991) 197-201.
8. Steenstrup, B.R., Alm, P., Hannibal, J., Jørgensen, J.Ch., Palle, C., Junge, J., Christensen, H.B., Ottesen, B. and Fahrenkrug, J., Pituitary adenylate cyclase activating polypeptide: occurrence and relaxant effect in the human female reproductive tract, Am. J. Physiol. 1995, in press.
9. Hannibal, J. and Fahrenkrug, J., Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells, Regul. Pept., 55 (1995) 111-115.
10. Steenstrup, B.R., Ottesen, B., Jørgensen, M. and Jørgensen, J.C., Pituitary adenylate cyclase activating polypeptide induces vascular relaxation and inhibits non-vascular smooth muscle activity in the rabbit female genital tract, Acta Physiol. Scand., 152 (1994) 129-136.
11. Hansen, V., Maigaard, S., Allen, J. and Forman, A., Effects of vasoactive intestinal polypeptide and substance P on human intramyometrial arteries and stem villous arteries in term pregnancy, Placenta, 9 (1988) 501-506.
12. Hannibal, J., Mikkelsen, J.D., Clausen, H., Holst, J.J., Wulff, B.S. and Fahrenkrug, J,. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus, Regul. Pept. 55 (1995) 133-148.
13. Johnson, C.D. and Arauja, C.M., A simple method of reducing the fading of immuno-fluorescence during microscopy, J. Immunol. Methods, 43 (1981) 349-350.
14. Lundberg, L.-M., Alm, P., Wharton, J. and Potak, J.M., Protein gene product 9.5 (PGP 9.5), a new neuronal marker for visualizing the whole uterine innervation and pregnancy-induced and developmental changes in the guinea pig, Histochemistry, 90 (1988) 9-17.
15. Maigaard, S., Högestätt, E.D., Forman, A. and Andersson, K.-E., Studies of isolated small vessels and myometrium from the human uteroplacental unit, Prog. Appl. Microcirc., 8 (1985) 75-81.
16. Högestätt, E.D., Andersson, K.-E. and Edvinsson, L., Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels, Acta Physiol. Scand., 117 (1983) 49-61.
17. Maigaard, S., Forman, A. and Andersson, K.-E., Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit, Acta Physiol. Scand., 128 (1986) 23-31.
18. Palle, C., Ottesen, B., Jørgensen, J. and Fahrenkrug, J., Peptide histidine methionine and vasoactive intestinal peptide: Occurrence and relaxant effect in the human reproductive tract, Biol. Reprod., 4 (1989) 1403-1411.
19. Sjöberg, N.-O., The adrenergic transmitter of the female reproductive tract. Distribution and functional changes, Acta Physiol. Scand., Suppl. 305 (1967) 5-32.
20. Nakanishi, H., McLean, J., Wood, C. and Burnstock, G.. The role of sympathetic nerves in control of the nonpregnant and pregnant human uterus, J. Reprod. Med., 11 (1969) 20-33.
21. Thorbert, G., Regional changes in structure and function of adrenergic nerves in guinea-pig uterus during pregnancy, Acta Obstet. Gynecol. Scand. 79 (Suppl.) (1979) 1-32.
22. Wikland, M., Lindblom, B., Dahlström, A. and Haglid, K., Structural and functional evidence for the denervation of human myometrium during pregnancy, Obstet. Gynecol., 64 (1984) 503-509.
23. Ottesen, B., Ulrichsen, H., Fahrenkrug, J., Larsen, J.-J., Wagner, G., Schierup, L. and Søndergaard, F., Vasoactive intestinal polypeptide and the female genital tract. Relationship to reproductive phase and delivery, Am. J. Obstet. Gynecol., 143 (1982) 414-420.
24. Warren, J.B., Donnelly, L.E. and Cullen, S., Pituitary adenylate cyclase activating polypeptide: a novel, long lasting endothelium-independent vasorelaxant, Eur. J. Pharmacol., 197 (1991) 131-134.
25. Absood, A., Chen, D., Wang, Z.-Y. and Håkanson, R., Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide, Regul. Pept., 40 (1992) 323-329.
26. Cardell, L.O., Uddman, R., Luts, A. and Sundler, F., Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects, Regul. Pept., 36 (1991) 379-390.
27. Warren, J.B., Cockcroft, J.R. and Larkin, S.W., Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans, J. Cardiovasc. Pharmacol., 20 (1992) 83-87.
28. Naruse, S., Suzuki, T., Ozaki, T. and Nokihara, K., Vasodilator effect of pituitary cyclase activating polypeptide (PACAP) on femoral blood flow in dogs, Peptides, 14 (1993) 505-510.
29. Nandha, K.A., Benito-Orfila, M.A., Smith, D.M., Ghatei, M.A. and Bloom, S.R., Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding, J. Endocrinol., 129 (1991) 69-73.
30. Uddman, R., Goadsby, P.J., Jansen, J. and Edvinsson, L., PACAP, a VIP-like peptide: Immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow, J. Cereb. Blood Flow Metab., 13 (1993) 291-297.
31. Cai, W.-Q., Bodin, P., Loesch, A., Sexton, A. and Burnstock, G., Localization of neuropeptide Y and atrial natriuretic peptide in the endothelial cells of human umbilical blood vessels, Cell Tissue Res., 272 (1993) 175-181.
32. Cai, W.-Q., Bodin, P., Loesch, A., Sexton, A. and Burnstock, G., Endothelium of human umbilical blood vessels: Ultrastructural immunolocalization of neuropeptides, J. Vasc. Res., 30 (1993) 348-355.